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Abstract
Background: b2-adrenoceptor (b2AR) gene polymorphism glutamine 27 glutamic acid (Gln27Glu) and Arg16Gly
were reported to have an association with obesity and obesity related disorders in some population. We evaluated
Gln27Glu polymorphism in the b2AR gene in obese Saudi populations to investigate the association of b2AR gene
with obesity and other related metabolic parameters.
Design: We studied possible association of Gln27Glu in b2AR gene with body mass index (BMI), anthropometric
measurements and other metabolic parameters. The b2AR gene polymorphism (Gln27Glu) was identified by
sequencing PCR products representing locus of interest. Based on BMI, the subjects were divided into three
groups, normal weight, overweight and obese. The genotype and allele frequency were calculated separately for
each group.
Results: The allelic frequency of Glu27 did not differ amongst the three groups, though the Glu27 homozygote
(Glu/Glu) were more in obese subjects and had higher concentration of triglyceride, leptin and insulin compared
to in the Gln27 heterozygotes and Gln/Gln homozygotes.
Conclusions: In this study we were able to provide evidence on the influence of Gln27Glu genetic variant of b2AR
gene on lipid phenotypes, insulin and leptin levels in the Saudi populations.
Background
Obesity is serious health problem among men and
women. It is a multifactorial phenotype determined by
genetic and non genetic factors including environmental
and behavioral characteristics [1]. Extensive studies have
been conducted in different populations to identify the
loci contributing to obesity development. In the process,
a complex picture has emerged where inter-population
differences in the susceptibility genes are observed. It
has been observed that catecholamines act through both
b-a n da adrenergic receptor which mediate through
different receptor pathways [2]. Genes involved in the
regulation of catecholamine function may be of particu-
lar importance for human obesity, since catecholamine
via b2-3 adrenergic receptors or adrenoceptors, regulate
body fat accumulation and play a central role in the reg-
ulation of energy expenditure [3]. This regulation is in
part affected by the stimulation of lipid mobilization
through lipolysis in fat cells, which has been associated
with obesity [4,5]. b2AR are expressed in many cell
types throughout the body and play a crucial role in the
regulation of the cardiac, pulmonary, vascular, endocrine
and central nervous system. Several functional poly-
morphisms occur within the coding region of this gene.
The Gln27Glu polymorphism in the b2AR gene has
been considered important factor contributing to obesity
[6]. Among these, a common mutation results is the
substitution of an amino acid in the extracellular
domain of the receptor, Gln27Glu [7]. This appears to
modify the extracellular part of the b2AR with possible
functional modification. * Correspondence: mahadaghestani@yahoo.com
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that this polymorphism is associated with obesity, insu-
lin resistance and dyslipidemia [8-10]. However, reports
from other populations contradict these results [11-13].
In some studies, gender differences in relation to the
polymorphism are reported [14-16]
In an attempt to elucidate the influence of the b2AR
polymorphisms on obesity development, we investigated
the association of Gln27Glu gene in obesity and its
influence on other metabolic profiles.
Materials and methods
Subjects
This study included 329 unrelated Saudi men (n = 109,
33.1%) and women (n = 220, 66.9%) aged 18 to
36 years, randomly chosen from a nationwide popula-
tion. All the study subjects gave their written consent to
participate in the study after being informed of its nat-
ure. The study was approved by local ethical committee
of the university. They agreed to have venous blood
drawn after an overnight fasting. For laboratory studies,
20 ml of blood was obtained in the morning following
an overnight (12 hour) fast. Blood samples were col-
lected in EDTA-coated tubes and immediately centri-
fuged at room temperature. The buffy coat and the
plasma were stored at -20°C until required for analysis.
Anthropometric Measurements
For each individual, anthropometric measurements were
made using standardized techniques. These included
measurement of height, weight, waist and hip circumfer-
ence and these were used to calculate BMI (kg/m
2), and
waist-to-hip ratio (WHR).
Biochemical Parameters
Plasma glucose level was estimated from the fresh sam-
ples by glucose-oxidase method adapted to an autoana-
lyzer (Hitachi 704, Boehringer Mannheim, GmBH,
Germany). Frozen plasma samples were thawed at room
temperature and used for the analysis of the other bio-
chemical parameters. The estimation of total cholesterol,
triglycerides, high density lipoprotein (HDL)-cholesterol
and low-density lipoprotein (LDL)-cholesterol were car-
ried out by enzymatic methods using commercial kits
(Boehringer Mannheim). Plasma insulin and leptin con-
centrations were determined by radioimmunoassay
(RIA; Human Insulin Specific RIA kit and Human Lep-
tin RIA Kit, respectively, Linco Research, St Louis, MO).
All analyses were conducted in duplicates. Quality con-
trol was maintained within and between the batches.
Genotyping of b2AR Polymorphism
Genomic DNA was extracted from peripheral blood leu-
cocytes using commercially available Gentra Systems Kit
(Minneapolis, MN, cat # D5500). The concentration and
purity of the DNA were estimated prior to analysis and
DNA was used for the following studies:
The DNA segment representing codon 27 of the
b2AR gene was amplified by polymerase chain reaction
(PCR) using forward (5′-AAGCTGAGTGTGCAG-
GACGA-3′) and reverse primers (5′-AGACGCTC-
GAACTTGGCAAT-3′). The PCR conditions consisted
of an initial denaturation step at 95°C for 15 minutes,
followed by 34 cycles of denaturation at 95°C for 1 min-
ute, annealing at 64°C for 1 minute, and extension at
72°C for 1 minute, with a final extension of 10 minutes
at 72°C. A PCR product of 353 bp was obtained.
Nucleotide sequencing was carried out using the ABI
Big Dye Terminator protocol on ABI 3100 Avant
Genetic Analyzer.
Statistical analysis
The subjects were grouped as normal weight (BMI
<2 5K g / m
2), overweight (BMI 25-29.9 Kg/m
2)a n d
Table 1 Mean comparisons of anthropometric
characteristics of the overweight and obese groups with
the normal control group
VARIABLES Control
Lean
(n = 115)
mean ± SE
Overweight
(n = 68) mean ±
SE
Obese
(n = 146)
mean ± SE
P
value
Age (yr)
M 25.9 ± 0.7 27.3 ± 0.67 26.7 ± 0.73 0. 056
F 24.5 ± 0.5 24.4 ± 0.7 26.7 ± 0.54
T 24.90 ± 0.44 25.56 ± 0.54 26.70 ± 0.43
BMI (kg/
m
2)
M 21.27 ± 0.34 26.4 ± 0.27 32.9 ± 0.8 0.0001
F 21.4 ± 0.20 27.3 ± 0.2 35.8 ± 0.6
T 21.33 ±
0.189
26.93 ± 0.170 34.89 ± 0.50
Waist (cm)
M 74.2 ± 1.53 86.1 ± 1.4 110.5 ± 2.2 0.0001
F 67.3 ± 0.9 84.4 ± 1.23 100.6 ± 1.38
T 70.82 ± 0.79 85.13 ± 0.93 103.72 ± 1.23
Hip (cm)
M 97.6 ± 1.2 100.8 ± 1.17 122.2 ± 2.0 0.0001
F 95.5 ± 0.8 102.2 ± 1.1 118.5 ± 1.4
T 96.13 ± 0.68 102.22 ± 0.821 119.68 ±
1.148
W/H Ratio
M 0.76 ± 0.02 0.86 ± 0.01 0.90 ± 0.01 0.0001
F 0.72 ± 0.01 0.82 ± 0.02 0.85 ± 0.007
T 0.73 ± 0.006 0.84 ± 0.006 0.87 ± 0.006
NOTE: Values are mean ± SEM. Abbreviations: BMI, body mass index; W/H,
waist hip ratio; M= Male; F= Female; T= Total.
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2), based on their BMI condi-
tions. The analysis was done using the Stat View pro-
gram for Windows (version 8.0; SAS) and the SPSS
(Statistical Package for Social Sciences; Version 13).
The data are presented as mean ± SEM for the males
and females separately. The comparisons of the results
of the overweight and obese subjects with the results of
the matched control were carried out using the indepen-
dent Students T-test and ANOVA test. The distribu-
tions of the age, BMI, anthropometric measurements,
lipid profile, fasting serum insulin, leptin and glucose
values of the study subjects according to their b2AR
gene were compared by the U Mann-Whitney test. Mul-
tivariable logistic regression was used to study the effect
of the b2AR genotype on BMI. Genotype and allele fre-
quency of b2AR alleles were calculated separately for
the normal weight, overweight and obese individuals
and compared using chi square analysis. Frequency dis-
tribution analysis was performed with chi square test.
Relative risk was estimated by the odds ratios (ORs) and
their 95% confidence intervals (CIs). A probability value
p ≤ 0.05 was considered statistically significant.
Results and discussion
Based on the BMI value, there were 35, 28, 46 males
and 80, 40, 100 females in the normal weight, over-
weight and obese groups, respectively. The demographic
characteristics of the male and female study subjects are
presented in Table 1. All the three groups matched in
their age and no significant differences were observed
amongst the groups. All other demographic parameters
were significantly higher in overweight and obese
Table 2 Comparison of the biochemical parameters of the overweight and obese groups with the normal control
group
VARIABLES Control Lean
(n = 115)
mean ± SE
Overweight
(n = 68) mean ± SE
Obese
(n = 146)
mean ± SE
P value
Cholesterol (mmol/L)
M 3.31 ± 0.07 4.4 ± 0.15 4.1 ± 0.11 0.0001
F 3.5 ± 0.05 4.05 ± 0.12 4.5 ± 0.09
T 3.43 ± 0.043 4.194 ± 0.096 4.4 ± 0.074
Triglyceride (mmol/L)
M 0.79 ± 0.05 1.15 ± 0.08 1.43 ± 0.07 0.0001
F 0.72 ± 0.05 1.03 ± 0.06 1.24 ± 0.04
T 0.742 ± 0.024 1.082 ± 0.05 1.302 ± 0.04
HDL-cholesterol (mmol/L)
M 1.28 ± 0.06 1.21 ± 0.07 1.08 ± 0.04 0.0001
F 1.34 ± 0.04 1.17 ± 0.05 1.06 ± 0.03
T 1.32 ± 0.033 1.19 ± 0.043 1.07 ± 0.024
LDL -cholesterol (mmol/L)
M 1.58 ± 0.09 2.25 ± 0.15 2.4 ± 0.11 0.0001
F 1.53 ± 0.06 1.94 ± 0.11 2. 6 ± 0.07
T 1.55 ± 0.05 2.07 ± 0.89 2.56 ± 0.059
Leptin (ng/ml)
M 3.10 ± 0.17 9.91 ± 0.38 17.6 ± 0.86 0.0001
F 12.2 ± 0.4 22.84 ± 0.97 44.6 ± 1.85
T 9.42 ± 0.48 17.51 ± 0.97 36.13 ± 1.67
Fasting Insulin (pmol/L)
M 62.6 ± 4.23 67.07 ± 5.27 111.9 ± 5.6 0.0001
F 54.85 ± 2.33 75.84 ± 6.26 103.3 ± 3.64
T 57.205 ± 2.089 72.23 ± 4.28 106.03 ± 3.066
Fasting Glucose (mmol/L)
M 4.84 ± 0.07 5.16 ± 0.05 5.06 ± 0.09 0.0001
F 4.65 ± 0.05 4.97 ± 0.08 5.06 ± 0.06
T 4.71 ± 0.041 5.051 ± 0.057 5.06 ± 0.05
NOTE: Values are mean ± SEM. Abbreviations: BMI, body mass index; W/H, waist hip ratio; M= Male; F= Female; T= Total.
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0.0001). The biochemical parameters in the three groups
of males and females are presented in Table 2. All para-
meters were significantly elevated in the overweight and
obese subjects, except HDL-cholesterol, which was sig-
nificantly lower compared to the normal weight group.
The genotype and allele frequency of the Gln27Glu
polymorphism was calculated in the male and females
and the results are presented in Table 3. The overweight
and obese subjects were separated from the normal
weight group and the Gln27Glu genotype and allele fre-
quency was calculated separately in each group. The
allelic frequency was not elevated significantly in the
overweight and obese female and male groups. However,
the Glu27 homozygote had significant greater BMI,
waist and hip circumference and significant higher con-
centration of triglyceride, leptin and insulin compared
to the Gln27 homozygote (Table 4).
The main findings of the present study show that the
male and female overweight and obese subjects do not
differ in the genotype and allele frequencies of Glu27,
however, the subjects who are Glu27 homozygote have
greater BMI, waist and hip circumference, but not
waist-to-hip ratios (abdominal obesity). These are asso-
ciated with higher levels of triglyceride, serum leptin
and insulin levels. There were no difference in the
alleles frequency amongst overweight, obese and the
control lean groups. These observations demonstrate
that the Glu27 genotype of the b2AR gene is related to
some obesity phenotypes and higher triglyceride, insulin
and leptin levels. Our results are in agreement with
those of many investigators who reported that the
Glu27Gln genotype of the b2AR gene has a well estab-
lished association with obesity [14]. Subjects who are
Glu27 homozygotes have excess body fat and increased
fat cell size compared with Gln homozygotes in a white
population and also suffers from abdominal obesity and
insulin resistance [15]. Similarly in another study Kun-
nas et al., observed significantly higher amount of visc-
eral fat in women with Glu allele compare to Gln/Gln
homozygote [17]. Masuo et al., have reported that the
mutations in the b2AR gene are associated with
increased insulin resistance, adiposity, and blood pres-
sure accompanied by higher plasma norepinephrine and
Table 3 Distribution of the genotypes, alleles frequencies and odd ratio of the b2 Gln27Glu polymorphism in
overweight and control subjects
Genotype Sex Control
M:35
F: 80
T=
115
Overweight
M:28
F: 40
T=6 8
Obese
M:46
F: 100 T =
146
c2
Odds ratio(95% CI)
P- value
Genotype Frequency
Gln\Gln M2 4
(68.57)
17 (60.7) 27 (58.67) c2
M= 1.19
F= 2.23
P value
M = 0.880
F5 1
(63.75)
26 (65) 60 (60)
T 75(65.2) 43(63.2) 87(59.6)
Gln\Glu M5
(14.28)
5 (17.58) 7 (15.21) Odds ratio (95% CI) Control vs
OW
1.1 (0.5, 2.39)
F = 0.693
F1 3
(16.25)
6 (15) 12 (12)
T 18(15.7) 11(16.2) 19(13.0)
Glu\Glu M6
(17.12)
6 (21.42) 12 (26) Odds ratio (95% CI) Control vs
Obese
1.567(0.85,2.87)
P value for Odds ratio in normal vs overweight and
normal vs obese:
P > 0.05
F 16 (20) 8 (20) 28 (28)
T 22(19.1) 14(20.6) 40(27.4)
Allele Frequency
Allele
Gln27
T 73.0% 71.3% 66.1% Odds ratio (95% CI) Control vs
OW
0.95 (0.71, 1.27)
P = 0.70
Allele
Glu27
T 27.0% 28.7% 33.9% Odds ratio (95% CI) Control vs
Obese
0.87 (0.74, 1.2)
P = 0.09
NOTE: M= Male; F= Female; T= Total; OW= Overweight; CI: Confidence interval
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Page 4 of 6leptin levels[16]. Ishiyama et al., have suggested an asso-
ciation of polymorphisms in the b2AR receptor gene
with obesity, hypertriglyceridemia, and diabetes mellitus
in Japanese subjects [18]. They observed that the
Gln27Glu heterozygotes were twice as common in obese
subjects, and that the frequency of the Glu27 allele was
also higher in patients with type 2 diabetes mellitus
than in nondiabetic subjects [18]. Another Japanese
study reported that the Gln27Glu b2AR receptor variant
was associated with obesity in males [19]. Ukkola et al.,
found that gene-to-gene interactions among the a2-, b2-
,a n db-adrenergic receptor genes contributed to the
phenotypic variability in abdominal obesity and plasma
lipid and lipoprotein in a family study in Québec [20].
Though, these and other studies show an association
between the Gln27Glu, however, there is considerable
debate on this association, because there have been sev-
eral studies that have failed to show the significant asso-
ciation between b2AR gene polymorphism and obesity
[11-13]. Hayakawa et al., reported that Gln27Glu and
Arg16Gly polymorphisms of the b2AR gene are not a
major contributing factor to obesity, blood pressure,
serum lipid levels, uric acid, or free fatty acid levels in
210 Japanese men [11]. Oberkofler et al., reported that
Gln27Glu polymorphisms in the b2AR gene is not a
major factor contributing to morbid obesity in Austrian
women [13]. Kim et al., found that the Glu27Glu and
Arg16Gly polymorphisms of the b2AR gene are not
major factor contributing towards obesity in Korean
subjects [21].
Furthermore, a few studies report gender-specific
association between b2AR polymorphism and obesity.
Hellstrom et al., suggested that a positive association
between obesity and the Glu27 genetic variant in b2AR
exists in females, whereas there is a negative correlation
between Glu27 and obesity in Swedish male subjects
[15]. Although the reasons for this discrepancy among
studies are unclear, they may be due to the difference in
the degree of obesity among study subjects or may be
due to genetic variations between ethnic groups. How-
ever, further studies in larger populations are required
to verify these results.
Our findings provide strong evidence on the influence of
the Gln27Glu genetic variants on lipid phenotypes, insulin
and leptin levels in overweight/obese Saudi subjects.
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